top of page

Brand Change: docusate sodium 50 mg with sennosides 8 mg tablet

ree

Kia ora

 

Brand Change:

We are writing to inform you of the brand change for docusate sodium 50 mg with sennosides 8 mg tablet.

 

Key Messages:

  • Solax a new brand of docusate sodium 50 mg with sennosides 8 mg, will be listed from 1 December 2025.

  • The Laxsol brand will be delisted 1 May 2026.

  • Please support your patients with this change. Although we do not anticipate problems, we are aware that the Laxsol brand has been available in NZ for many years.

  • The Solax tablets and Laxsol tablets have a similar appearance as seen on our webpage - Solax tablets on Pharmac website

 

Please share this information:

Please share this information with your colleagues and within your networks.

 

Questions: 

If you have any queries, please contact us at enquiry@pharmac.govt.nz

 

If you no longer wish to receive emails from the Pharmac Implementation Team, please send a reply email with UNSUBSCRIBE in the subject heading. Thank you.

 

 Ngā mihi,

 

Anna  I Senior Advisor Implementation

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

P: 0800 660 050 | www.pharmac.govt.nz

bottom of page